Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.6950 per EA under NDC 33342025666. Its NADAC has been published 387 times since Mar 27, 2019.
FDA first approved this application on Sep 14, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342025666
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA207211FDA Approved
9/14/2017
TE Code
AB
On Market Since
9/21/2017
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 387 times since Mar 27, 2019, and over the history we have for it it has declined 87.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6950 per EA |
|---|---|
| All-time high | $5.7221 (Apr 10, 2019) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $1.4011 |
| Average price | $2.1118 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 387 |
| Tracking since | Mar 27, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Macleods Pharmaceuticals Limited, is $0.6950 per EA (NDC 33342025666), effective Aug 19, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 87.9%. It has been tracked across 387 weekly CMS publications since Mar 27, 2019.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Mar 27, 2019, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $5.7221 (Apr 10, 2019), with a median of $1.4011 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR PHOS 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 33342025666) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.